If you liked this article you might like

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season
Biotech Movers: Synergy, Biogen, Insys
Why Biotech Investors Should Worry When Their Stocks Turn Boring
Valuation Is in the Eye of the Buyer: Cramer's 'Mad Money' Recap (Tuesday 4/4/17)